$28.86
-2.08-6.71%
Last update: Nov 5, 3:48 PM

The average analyst price target for Zymeworks is $39.62, 37.3% above the current price. Of 13 analysts, 13 rate it Buy. Targets range from $14 to $58. The latest change came on Oct 28, 2026, when Truist Securities raised its price target on Zymeworks from $34 to $35 and kept a Buy rating.
Price Target Range — 11 Quarters
Analyst Consensus — 13 Analysts
Rating Trend — Last 9 Months